Test Price
1,200 AED✅ Home Collection Available
BCR-ABL Major Quantitative Test – 1200 AED
Executive Summary & Core Metrics
- Accuracy Assurance: 99.9% diagnostic sensitivity via ISO-certified real-time PCR.
- Premium Services: VIP mobile phlebotomy & temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Post-test telephone consultation for result interpretation.
- Insurance Verification: Direct coverage check via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The BCR-ABL Major Quantitative Test precisely quantifies the BCR-ABL1 fusion transcript in peripheral blood or bone marrow using real-time PCR. It is essential for monitoring treatment response in chronic myeloid leukemia (CML) and detecting minimal residual disease. This ISO‑certified assay delivers results within 24–36 hours, enabling timely clinical decisions.
| Parameter | Our BCR-ABL Major Quantitative | Standard BCR-ABL qPCR |
|---|---|---|
| Methodology | Real‑Time PCR (qPCR) + Whole Genome Sequencing (WGS) | Real‑Time PCR only |
| Precision & Sensitivity | International Scale (IS)‑calibrated, MR4.5, 99.9% precision | IS‑calibrated, MR4.0, ~95% precision |
| Turnaround Time | 24–36 hours (phone & email) | 48–72 hours |
Physician Insight & Safety Protocols
“The BCR-ABL quantitative assay is the cornerstone of CML monitoring. Accurate measurement reflects molecular remission depth, guiding imatinib or second-generation TKI therapy. Always interpret results alongside clinical status and complete blood counts; a rising transcript may signal non-compliance or resistance. We are here to support you every step of your journey.”
Medication Advisory
⚠️ Do not discontinue prescribed medication without consulting your doctor. Continue all treatments as directed until your physician advises otherwise.
Exclusion Criteria & Red Flags
- Active systemic infection or fever
- Severe anemia (Hb <8 g/dL) requiring transfusion prior to draw
- Bleeding diathesis (platelets <30×10⁹/L)
- Inability to provide informed consent
- Emergency Red Flags: Sudden visual changes, priapism, severe bone pain, respiratory distress, neurological deficits — immediate ER attention required.
Patient FAQ & Clinical Guidance
1. What is the BCR-ABL Major Quantitative Test used for?
This test quantifies the BCR-ABL1 gene transcript to monitor treatment response and detect minimal residual disease in CML patients. It measures the level of the abnormal BCR-ABL1 fusion gene, providing a precise indicator of how well targeted therapy is working and whether deeper molecular remission is achieved.
2. Do I need to fast before the BCR-ABL test?
No fasting is required; however, follow all pre-instructions, including signing the consent document and providing your complete clinical history. You may continue your regular diet and medications unless otherwise directed by your physician.
3. How quickly will I receive my BCR-ABL results?
Results are delivered within 24–36 hours via phone and secure email, with verbal urgent notification in critical cases. Our laboratory processes samples three working days a week and prioritizes rapid reporting for clinical decision-making.
UAE Regulatory & Data Privacy Adherence
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – Ensures strict confidentiality and secure processing of patient medical data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Governs digital health records and telehealth communications.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Outlines clinical safety, informed consent, and patient rights.
- ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) – International quality management standard for laboratory services.
Clinical & Logistical Metadata
| Test Name | BCR-ABL Major Quantitative Test |
| Price (AED) | 1,200 |
| Turnaround Time | 24–36 hours |
| Sample Type / Matrix | Peripheral blood (preferred) or bone marrow aspirate (hospital collection only) |
| Methodology Used | Real‑Time PCR (qPCR) + Whole Genome Sequencing (WGS) |
| ICD-10-CM Code | C92.1 |
| LOINC Code | 51568-7 |
| DHA Facility License & Laboratory Address | DHA License No. 1143, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians